Vera Therapeutics Inc is a clinical stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VERA is expected to report earnings to rise 2.00% to -73 cents per share on May 08
Q1'25
Est.
$-0.73
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.03
The last earnings report on February 26 showed earnings per share of -72 cents, beating the estimate of -81 cents. With 816.63K shares outstanding, the current market capitalization sits at 1.50B.